GTR Home > Tests > Search results - Sitosterolemia

Apply filters

Showing test for 1 condition

reset

Compare labs

Your search term can be found in tests with a total of 2096 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states

GTR test search results for C0342907[DISCUI]

C Clinical test, R Research test

Showing 1 to 20 of 20 tests for 1 condition in 9 labs

CHyperlipidemia Panel

Lab: Blueprint Genetics Helsinki, Southern Finland, Finland
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (6)
Total targets (10)

CTruGenome Predisposition Screen (Whole Genome Sequencing)

Lab: Illumina Clinical Services Laboratory Illumina San Diego, California, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (1541)
Total targets (1578)

CABCG5. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

CABCG8. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

CABCG8 Gene Sequencing

Test targets
Methods
  • C Sequence analysis of the entire coding region

CABCG5 Gene Sequencing

Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

CSitosterolemia NGS Panel

Test targets
Methods
  • C Sequence analysis of the entire coding region

CSitosterolemia

Lab: Bioarray Elche, Comunidad Valenciana, Spain
Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

CSitosterolemia

Lab: Bioarray Elche, Comunidad Valenciana, Spain
Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

CABCG8 Sequencing

Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CABCG5 Sequencing

Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CABCG8

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CABCG5

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Conditions
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CNeonatal and Adult Cholestasis: Sequencing Panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (99)
Total targets (57)

CIntellectual Disability NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (752)
Total targets (392)

CAmyotrophic Lateral Sclerosis NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (47)
Total targets (24)

CRed Blood Cell Membrane Disorders panel by next-generation sequencing (NGS)

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (14)
Total targets (12)

CSitosterolemia, ABCG8, Sequencing

Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

CSitosterolemia, ABCG5, Sequencing

Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

Showing 1 to 20 of 20 tests for 1 condition in 9 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.